Results 221 to 230 of about 274,237 (307)

Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in <i>Mycobacterium avium</i> complex pulmonary disease. [PDF]

J Clin Tuberc Other Mycobact Dis
Teramoto T, Ito A, Nakanishi Y, Hashimoto T, Ishida T.   +4 more
europepmc   +1 more source

Navigating adverse immunostimulation: A practical guide for clinical researchers

British Journal of Clinical Pharmacology, EarlyView.
Problem Setting As drug development moves towards more complex products, early clinical development programmes are increasingly hampered by unwanted and/or unexpected activation of the immune system (adverse immune stimulation, AIS). Solution At the Centre for Human Drug Research, we have introduced standardized procedures to make AIS manageable, while
Juliette A. van den Noort, Anouk C. Meijs, Naomi B. Klarenbeek, Matthijs Moerland   +3 more
wiley   +1 more source

Forsythiaside A Alleviates LPS-Induced Mastitis by Inhibiting Ferroptosis and Oxidative Stress. [PDF]

Animals (Basel)
Hao Z, Shi K, Tong J, Zhang R, Li X, Wang L, Yao X, Fan Y, Yang X, Li X, Tong C, Wang X.   +11 more
europepmc   +1 more source

Quality indicators for safe and effective medication use in long‐term care facilities: A modified Delphi study

British Journal of Clinical Pharmacology, EarlyView.
Aim This modified Delphi study aimed to achieve expert agreement on quality indicators (QIs) suitable for application at the population level, to evaluate quality use of medications and pharmacist services in long‐term care facilities (LTCFs). Methods We conducted a two‐round modified online Delphi study with a multidisciplinary panel of Australian ...
Daria S. Gutteridge, Sara Javanparast, Annabel H. Calder, Gillian E. Caughey, Andrew C. Stafford, Gregory M. Peterson, Maria C. Inacio, Peter D. Hibbert, Elizabeth Manias, Jodie B. Hillen, Janet K. Sluggett   +10 more
wiley   +1 more source

Enhancing and optimization for efficient removal of nickel ions by modified activated carbon. [PDF]

Sci Rep
Abdel-Moniem SM, Mohammed R, Ibrahim HS, Ali MEM.   +3 more
europepmc   +1 more source

A scoping review of quality prescribing indicators, rules and criteria for primary care

British Journal of Clinical Pharmacology, EarlyView.
Medication‐related problems (MRPs) place a substantial burden on the healthcare system, contributing to hospital admissions and significant healthcare costs. Quality prescribing indicators (QPIs), rules and criteria serve to educate prescribers about high risk MRPs and to monitor prescribing behaviours. This study aims to summarize existing indicators,
James Nind, Anna Mackintosh, Emma Maddock, Alana Delaforce, Gregory Peterson, Elizabeth Manias, Johnson George   +6 more
wiley   +1 more source

Correction: Intravenous thrombolysis for acute central retinal artery occlusion: Protocol for a systematic review and individual participant data meta-analysis of randomized controlled trials. [PDF]

PLoS One
Grory BM, Preterre C, Lebranchu P, Ryan SJ, Jørstad ØK, Moe MC, Tünnerhoff J, Spitzer MS, Grohmann C, Dumitrascu OM, Biousse V, Guillon B, Aamodt AH, Poli S, Schrag M, Central Retinal ArterY OcclusioN (CRAYON) Collaborators.   +15 more
europepmc   +1 more source

Lost and found in translation: the value of the human imiquimod model

British Journal of Clinical Pharmacology, EarlyView.
Topical imiquimod (IMQ), a Toll‐like receptor (TLR) 7 agonist, induces transient cutaneous inflammation and is widely used in preclinical research as a ‘psoriasis‐like’ mouse model. However, accumulating evidence indicates substantial divergence between IMQ‐driven biology and human plaque psoriasis pathogenesis.
Anouk C. Meijs, Juliette A. van den Noort, Salma Assil, Naomi B. Klarenbeek, Matthijs Moerland, Tessa Niemeyer‐van der Kolk, Robert Rissmann   +6 more
wiley   +1 more source

Efficacy of drug regimens containing omadacycline in a murine model of <i>Mycobacterium avium</i> chronic lung infection. [PDF]

Front Microbiol
Lanoix JP, Froment A, Delomez J, Pierce JV, Serio AW, Choquet M, Perret M, Peltier F, Joseph C, Chatelain D, Andréjak C.   +10 more
europepmc   +1 more source